Coronavirus pandemic has been defeated in other nations but not in America. CDC needs White House to provide the leadership, says Dr. David Satcher. USA TODAY
Sweden's approach to COVID has led to death, grief and suffering. The only example we're setting is how not to deal with a deadly infectious disease.
Sweden has often been considered a leader when it comes to global humanitarian issues, regarded as a beacon of light in areas such asaccepting refugees and working against global warming. In the COVID-19 pandemic, Sweden has also created interest around the world by following its own path of using a soft approach not locking down, introducing mostly voluntary restrictions and spurning the use of masks.
This approach has been perceived as more liberal and has shown up in Be Like Sweden signs and chants at U.S. protests.Wherever measures have been lenient, though, death rates have peaked. In the United States, areas that are coming out of lockdown early are suffering, and we are seeing the same in other countries as well.
The motives for the SwedishPublic Health Agency's light-touch approach are somewhat of a mystery. Some other countries that initially used this strategy swiftly abandoned it as the death toll began to increase, opting instead for delayed lockdowns. But Sweden has been faithful to its approach.
Why? Gaining herd immunity, where large numbers of the population (preferably younger) are infected and thereby develop immunity, has not been an official goal of the Swedish Public Health Agency. But it has said immunity in the population could help suppress the spread of the disease, and some agency statements suggest it is the secret goal.
Further evidence of this is thatthe agency insists on mandatory schooling for young children, the importance of testing has been played down for a long time, the agency refused to acknowledge the importance of asymptomatic spread of the virus (concerningly, it hasencouraged those in households withCOVID-19 infected individuals to go to work and school) and still refuses to recommend masks in public, despite the overwhelming evidence of their effectiveness. In addition, the stated goal of the Swedish authorities was always not to minimize the epidemic, but rather slow it down, so that the health care system wouldnt be overwhelmed.
People outside a restaurant without masks or social distancing on July 17, 2020 in Gotland, Sweden.(Photo: Martin von Krogh/Getty Images)
Several authorities, including the World Health Organization, have condemned herd immunity as a strategy. "It can lead to a very brutal arithmetic that does not put people and life and suffering at the center of that equation, Dr. Mike Ryan, executive director of WHO'sHealth Emergencies Program, said at a press conference in May.
With COVID-19, dont only focus on death: Too many Americans are alive and in misery.
Regardless of whetherherd immunity is a goal or a side effect of the Swedish strategy, how has it worked out? Not so well, according to the agencys own test results. The proportion of Swedes carrying antibodies is estimated to beunder 10%, thus nowhere near herd immunity. And yet, the Swedish death rate is unnerving. Sweden has a death toll greater than the United States: 556 deaths per million inhabitants,compared with 425, as of July 20.
Sweden also has a death toll more than four and a half times greater than that of the other four Nordic countries combined more than seven times greater per million inhabitants. For a number of weeks, Sweden has been among the top in the world when it comes to current reported deaths per capita. And despite this, the strategy in essence remains the same.
It is possible that the Public Health Authority actually believed that the Swedish approach was the most appropriate and sustainable one, and that the other countries, many of which went into lockdown, would do worse. Perhaps this, and not herd immunity, is the main reason the authorities are desperately clinging to their strategy. Or perhaps an unwillingness to admit early mistakes and take responsibility for thousands of unnecessary deaths plays into this resistance to change. Nevertheless, the result at this stage is unequivocal.
Social distancing matters. Here is how to do it and how it can help curb the COVID-19 pandemic. USA TODAY
Adopting the Swedish model: Coronavirus doesn't care about public opinion and it still kills
We do believe Sweden can be used as a model, but not in the way it was thought of initially. It can instead serve as a control group and answer the question of how efficient the voluntary distancing and loose measures in Sweden are compared to lockdowns, aggressive testing, tracing and the use of masks.
In Sweden, the strategy has led to death, grief and suffering and on top of that there are no indications that the Swedish economy has fared better than in many other countries. At the moment, we have set an example for the rest of the world on how not to deal with a deadly infectious disease.
In the end, this too shall pass and life will eventually return to normal. New medical treatments will come and improve the prognosis. Hopefully there will be a vaccine. Stick it out until then. And dont do it the Swedish way.
Sigurd Bergmann, Ph.D., Emeritus Professor, Norwegian University of Science and Technology
Dr. Leif Bjermer. Ph.D., Professor, Respiratory Medicine and Allergology, Lund University
Barbara Caracciolo, Ph.D., in Epidemiology
Marcus Carlsson, Ph.D., Associate Professor of Mathematics, Lund University
Dr. Lena Einhorn, Ph.D., in Virology
Dr. Stefan Einhorn, Ph.D.,Professor of Molecular Oncology, Karolinska Institutet
Andrew Ewing, Ph.D., Professor of Chemistry and Molecular Biology, University of Gothenburg
Dr. Manuel Felices, Ph.D.,Head of Endocrine Surgery, NL Hospital
Dr. Jonas Frisn, Ph.D.,Professor of Stem Cell Research, Karolinska Institutet
Marie Gorwa, Ph.D., Professor of Microbiology, Lund University
Dr. ke Gustafsson, Ph.D.,Clinical Microbiology, Uppsala University Hospital
Dr. Olle Isacsson, Ph.D., Professor of Endocrinology, University of Gothenburg
Dr. Claudia Hanson, Ph.D., Associate professor, Global public health, Karolinska Institutet
Dr. Stefan Hanson, Ph.D., International Health, Karolinska Institutet.
Dr. Jan Ltvall, Ph.D., Professor of Clinical Allergy, University of Gothenburg
Dr. Bo Lundbck, Ph.D.,Professor of Epidemiology of Respiratory Diseases, University of Gothenburg
ke Lundkvist,Ph.D., Professor of Virology, Uppsala University
Dr. Cecilia Sderberg-Nauclr, Ph.D.,Professor of Microbial Pathogenesis, Karolinska Institutet
Finn Nilson, Ph.D., Associate Professor of Risk Management, Karlstad University
Andreas Nilsson, Ph.D., Professor of Psychology, University of Gothenburg
Dr. Bjrn Olsen, Ph.D., Professor of Infectious Diseases, Uppsala University
Jens Stilhoff Srensen, Ph.D., Associate Professor, School of Global Studies, University of Gothenburg
Jakob Svensson, Ph.D., Scientific Data Analysis, Max Planck Institute, Greifswald
Dr. Anders Vahlne, Ph.D., Professor of Clinical Virology, Karolinska Institutet
Dr. Anders Wahlin, Ph.D., Professor Emeritus of Hematology, University of Ume
Autoplay
Show Thumbnails
Show Captions
Read or Share this story: https://www.usatoday.com/story/opinion/2020/07/21/coronavirus-swedish-herd-immunity-drove-up-death-toll-column/5472100002/
Read this article:
Sweden hoped herd immunity would curb COVID-19. Don't do what we did. It's not working. - USA TODAY
- Podcast 9 Athens part 3 and news - November 8th, 2009 [November 8th, 2009]
- Podcast 10 Athens part 4 - November 8th, 2009 [November 8th, 2009]
- Podcast 11 Athens Part 5 - November 8th, 2009 [November 8th, 2009]
- Episode 12 Cardiac Nuclear Medicine in the UK - November 8th, 2009 [November 8th, 2009]
- Podcast 13 Choline PET and prostate cancer - November 8th, 2009 [November 8th, 2009]
- Episode14 ED function and Dysponea - November 8th, 2009 [November 8th, 2009]
- ep 15 Collimator Choice and Reconstruction algorithm - November 8th, 2009 [November 8th, 2009]
- Episode 16 Dr Strauss on vulnerable plaque - November 8th, 2009 [November 8th, 2009]
- Episode17 Chemical Stress - November 8th, 2009 [November 8th, 2009]
- Episode 18 Myocardial Perfusion Imaging and Diabetes - November 8th, 2009 [November 8th, 2009]
- Episode 19 The INSPIRE trial - November 8th, 2009 [November 8th, 2009]
- 20 Dual isotope with a difference - November 8th, 2009 [November 8th, 2009]
- Episode 21 The real effect of stress - November 8th, 2009 [November 8th, 2009]
- Episode 22 D-SPECT - November 8th, 2009 [November 8th, 2009]
- Episode 23 VQ Reprise - November 8th, 2009 [November 8th, 2009]
- Episode 24 Hepatobiliary Nuclear Medicine - November 8th, 2009 [November 8th, 2009]
- Episode 25 Sleep Apnea - November 8th, 2009 [November 8th, 2009]
- Episode 26 Imaging Post Traumatic Stress Disorder - November 8th, 2009 [November 8th, 2009]
- Episode 27 Cardiac Stem Cells - November 8th, 2009 [November 8th, 2009]
- Episode 28 Molly Supply - November 8th, 2009 [November 8th, 2009]
- Episode 29 Melanoma therapy interview with Dr Ekaterina Dadachova - November 8th, 2009 [November 8th, 2009]
- Episode 30 Viral Therapy - November 8th, 2009 [November 8th, 2009]
- Episode 31 breast radiotherapy using radioisotopes - November 8th, 2009 [November 8th, 2009]
- Episode 32 news from snm - November 8th, 2009 [November 8th, 2009]
- Episode 33 EBV Imaging and Therapy - November 8th, 2009 [November 8th, 2009]
- Episode 34 Dr Lele SNM India 2009 - December 14th, 2009 [December 14th, 2009]
- Episode 35 Dr Andrew Scott from the Ludwig institute - January 10th, 2010 [January 10th, 2010]
- Episode 36 CardiArc - February 25th, 2010 [February 25th, 2010]
- Episode 37 Dr Modder Radiosynoviorthesis (Radiation Synovectomy) - March 31st, 2010 [March 31st, 2010]
- Episode 38 Indian Nuclear Medicine With Dr Malhotra and Dr Krishna - May 28th, 2010 [May 28th, 2010]
- Episode 39 Prof Ora Israel The Utility of Hybrid Imaging - July 13th, 2010 [July 13th, 2010]
- Episode 40 New V/Q SPECT developments - October 11th, 2010 [October 11th, 2010]
- Episode 41 scintimun - February 14th, 2011 [February 14th, 2011]
- Episode 42 Radio-Isotope Supply into the future - March 6th, 2011 [March 6th, 2011]
- Podcast 4: DNA therapy - April 24th, 2011 [April 24th, 2011]
- Sorry about the delay a new podcast will be out soon! - April 24th, 2011 [April 24th, 2011]
- Podcast 5 Flash 3D - April 24th, 2011 [April 24th, 2011]
- Podcast 6 Affibody - April 24th, 2011 [April 24th, 2011]
- Podcast 7 EANM 2006 Athens Part 1 - April 24th, 2011 [April 24th, 2011]
- Podcast 8 Athens Part 2 - April 24th, 2011 [April 24th, 2011]
- Episode 43 Rapidscan Part 1, 720P high quality video version - May 1st, 2011 [May 1st, 2011]
- Episode 43 Rapidscan Part 1, Ipod quality video - May 1st, 2011 [May 1st, 2011]
- Episode 43 Rapidscan Part 1, Audio version - May 1st, 2011 [May 1st, 2011]
- Episode 45 Mummies with cardiovascular disease video - May 21st, 2011 [May 21st, 2011]
- Episode 45 Mummies with cardiovascular disease audio edition - May 21st, 2011 [May 21st, 2011]
- Episode 46 Dr Gordon DePuey Choosing Reconstruction clinical perspective - August 7th, 2011 [August 7th, 2011]
- Episode 46 Dr Gordon DePuey Choosing Reconstruction clinical perspective audio version - August 7th, 2011 [August 7th, 2011]
- Episode 47 Cardiac Image Fusion With Dr Kaufmann - September 18th, 2011 [September 18th, 2011]
- Episode 47 Cardiac Fusion with Dr Kaufmann video version - September 18th, 2011 [September 18th, 2011]
- Dear Steve, I am and many more like me are your one more thing. - October 9th, 2011 [October 9th, 2011]
- EPISODE 48 PET MRI camera from Siemens with Dr Georgi audio - October 23rd, 2011 [October 23rd, 2011]
- EPISODE 48 PET MRI camera from Siemens Dr Georgi video - October 23rd, 2011 [October 23rd, 2011]
- Silicon Biosystems to Present Single-Circulating Tumor Cell Molecular Characterization at the Fourth World CTC Summit - April 25th, 2012 [April 25th, 2012]
- Leukaemia cells have a remembrance of things past - April 25th, 2012 [April 25th, 2012]
- Technologist Education Requirements Can Help Cut Repeat Scans - April 25th, 2012 [April 25th, 2012]
- HKU Collaborative Research Discovers A Novel Molecular Mechanism Of A New Anti-HIV-1 Drug Candidate - April 25th, 2012 [April 25th, 2012]
- Focal Segmental Glomerulosclerosis and the Nephrotic Syndrome - Part 1 Clinical - Video - May 4th, 2012 [May 4th, 2012]
- Electro-Medicine : Biological Physics - The Molecular Basis of Alzheimers Disease - Video - May 4th, 2012 [May 4th, 2012]
- osdd heterocyclic compounds and molecular medicines - Video - May 4th, 2012 [May 4th, 2012]
- Molecule to Medicine: The Biomarker Frontier - Video - May 4th, 2012 [May 4th, 2012]
- Fulfilling the Promise of Molecular Medicine in a Developmental Brain Disorder - Video - May 4th, 2012 [May 4th, 2012]
- Focus on Stefanie Dimmeler - Video - May 4th, 2012 [May 4th, 2012]
- Dundee - May 4th, 2012 [May 4th, 2012]
- Nanotechnology In Medicine: Huge Potential, But What Are The Risks? - May 5th, 2012 [May 5th, 2012]
- Cutting Edge Technology Coming To DMH - May 5th, 2012 [May 5th, 2012]
- This Week in Experimental and Molecular Pathology - May 5th, 2012 [May 5th, 2012]
- Researchers' discovery offers hope for cancer, heart disease miracle drugs - May 7th, 2012 [May 7th, 2012]
- Penn State student Zachary Hostetler from Garnet Valley is being honored as a student marshal - May 7th, 2012 [May 7th, 2012]
- NCKU Student Wins Prestigious Award for Anti-Cancer Research - May 10th, 2012 [May 10th, 2012]
- In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers ... - May 10th, 2012 [May 10th, 2012]
- Pitt team uses genomics to identify a molecular-based treatment for a viral skin cancer - May 10th, 2012 [May 10th, 2012]
- Genomics used to identify a molecular-based treatment for a viral skin cancer - May 10th, 2012 [May 10th, 2012]
- 2 molecular biologists get $500K medical prize - May 13th, 2012 [May 13th, 2012]
- 2 molecular biologists share $500K medical prize - May 13th, 2012 [May 13th, 2012]
- Lab21 Unveils New Molecular Analysis Services at Greenville Site - May 13th, 2012 [May 13th, 2012]
- 2 molecular biologists from NYC to share $500K medical prize for pioneering research on cells - May 13th, 2012 [May 13th, 2012]
- Two Molecular Biologists Get $500K Medical Prize - May 13th, 2012 [May 13th, 2012]
- Pair of molecular biologists receive Albany Medical Center Prize - May 13th, 2012 [May 13th, 2012]
- CNIO scientists successfully test the first gene therapy against aging-associated decline - May 16th, 2012 [May 16th, 2012]
- Cancer Institute of New Jersey Aims to Advance Personalized Cancer Treatments Through 'Precision Medicine' - May 16th, 2012 [May 16th, 2012]